Prof. Dr. GÜNGÖR UTKAN

Yayın Ağı

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

Exploring the connection between microsatellite instability and inflammatory indicators in cancers

Karaoglan B. B., SAVAŞ B., Utkan G., Urun Y.

FUTURE ONCOLOGY , 2024 (SCI-Expanded)

Distributions and prognostic effects of ABO/Rh blood groups in patients with HER2/neu positive gastric and gastroesophageal junction cancer

Dogan I., Gurbuz M., Aydin E., Karabulut S., Tastekin D., UTKAN G.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , cilt.19, 2023 (SCI-Expanded)

Short-Course Radiotherapy Followed by Consolidation Chemotherapy Is Safe and Effective in Locally Advanced Rectal Cancer: Comparative Short-term Results of Multicenter Propensity Score Case-Matched Study

BENLİCE Ç., KOÇ M. A., Gulcu B., BİLGİN İ. A., AKYOL C., BACA B., et al.

DISEASES OF THE COLON & RECTUM , cilt.66, sa.5, ss.681-690, 2023 (SCI-Expanded)

Short-Course Radiotherapy Followed by Consolidation Chemotherapy Is Safe and Effective in Locally Advanced Rectal Cancer: Comparative Short-term Results of Multicenter Propensity Score Case-Matched Study

BENLİCE Ç., KOÇ M. A., Gulcu B., BİLGİN İ. A., AKYOL C., Baca B., et al.

DISEASES OF THE COLON & RECTUM , sa.5, 2023 (SCI-Expanded)

The effect of primary tumour resection on patients with synchronous metastatic colorectal cancer treated with cetuximab-containing regimens

Sertesen E., Yekeduz E., KÖKSOY E. B., ÜRÜN Y., ERKEK A. B., DEMİRCİ S., et al.

ANZ JOURNAL OF SURGERY , cilt.93, sa.4, ss.945-950, 2023 (SCI-Expanded)

Prognostic role of pan-immune-inflammation value in patients with metastatic castration-resistant prostate cancer treated with androgen receptor-signaling inhibitors

YAZGAN S. C., Yekeduz E., UTKAN G., ÜRÜN Y.

PROSTATE , cilt.82, sa.15, ss.1456-1461, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

Chronic hyperglycemia based on diabetes is independently associated with decreased survival in patients with advanced cancer treated with immune checkpoint inhibitors

Yekeduz E., KÖKSOY E. B., YAZGAN S. C., KARATAŞ G., ÇAY ŞENLER F., UTKAN G., et al.

ANTI-CANCER DRUGS , cilt.33, sa.10, ss.1145-1149, 2022 (SCI-Expanded)

The prognostic role of polypharmacy in metastatic colorectal cancer patients treated with regorafenib

Yekeduz E., Aktas E. G., KÖKSOY E. B., Dogan N., ÜRÜN Y., UTKAN G.

FUTURE ONCOLOGY , cilt.18, ss.1067-1076, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: A multicenter study

Yekeduz E., Ozbay M. F., Caglayan D., Yildirim A., Erol C., Yildirim H. C., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.40, sa.4, 2022 (SCI-Expanded)

Key considerations and common adverse events for HIV-positive patients with cancer treated with immune checkpoint inhibitors

Yekeduz E., UTKAN G., ÜRÜN Y.

FUTURE ONCOLOGY , cilt.18, ss.413-416, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

Efficacy and tolerability of vismodegib treatment in locally advanced and metastatic basal cell carcinoma: Retrospective real-life data

Gurbuz M., DOĞAN İ., AKKUŞ E., ERMİŞ H., UTKAN G., Vatansever S., et al.

DERMATOLOGIC THERAPY , cilt.34, 2021 (SCI-Expanded)

Neurotoxicities of novel non-steroidal anti-androgens for prostate cancer: A systematic review and meta-analysis

Bakouny Z., Yekeduz E., Braun D. A., Berchuck J. E., Hirsch L., UTKAN G., et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , cilt.166, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

Assessing population diversity in phase III trials of cancer drugs supporting Food and Drug Administration approval in solid tumors

Yekeduz E., Trapani D., Xu W., de Vries E. G. E., Labaki C., Gyawali B., et al.

INTERNATIONAL JOURNAL OF CANCER , cilt.149, sa.7, ss.1455-1462, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

mRNA-based COVID-19 vaccines appear not to increase immune events in cancer patients receiving immune checkpoint inhibitors

Yekeduz E., Ayasun R., KÖKSOY E. B., UTKAN G., ÜRÜN Y., AKBULUT H.

FUTURE VIROLOGY , cilt.16, sa.9, ss.583-585, 2021 (SCI-Expanded)

Response to letter entitled: Re: A systematic review and meta-analysis: The effect of active cancer treatment on severity of COVID-19

Yekeduz E., UTKAN G., ÜRÜN Y.

EUROPEAN JOURNAL OF CANCER , cilt.152, ss.248-249, 2021 (SCI-Expanded)

In the Age of Immunotherapy, How Can We Translate the CARMENA Results into Practice?

Yekeduz E., SÜER E., UTKAN G., BALTACI S., ÜRÜN Y.

EUROPEAN UROLOGY ONCOLOGY , cilt.4, sa.3, ss.515-516, 2021 (SCI-Expanded)

Commentary: Should all cancer patients be tested for COVID-19 before each chemotherapy cycle?

Yekeduz E., UTKAN G., ÜRÜN Y.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.27, sa.2, ss.450-452, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

Expanding armamentarium in advanced prostate cancer management: are all novel antiandrogens the same?

Yekeduz E., UTKAN G., Kanesvaran R., ÜRÜN Y.

PROSTATE INTERNATIONAL , cilt.9, sa.1, ss.1-5, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

A retrospective multicenter study: Clinicopathological factors affecting recurrence-free survival in operable gastric cancer patients.

Yekeduz E., Dogan I., AKBULUT H., Karabulut S., UTKAN G., ÜRÜN Y.

JOURNAL OF CLINICAL ONCOLOGY , cilt.39, sa.3, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

Osteopontin is a Prognostic Factor in Patients with Advanced Gastric Cancer

YAZICI O., Dogan M., Ozal G., AKTAŞ S. H., Demirkazik A., UTKAN G., et al.

COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING , cilt.24, sa.8, ss.1229-1235, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

ctDNA as a prognostic factor in operable colon cancer patients: a systematic review and meta-analysis

Yekeduz E., KÖKSOY E. B., AKBULUT H., ÜRÜN Y., UTKAN G.

FUTURE ONCOLOGY , cilt.17, sa.03, ss.349-357, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

Prevalence, etiology and risk factors of anemia in patients with newly diagnosed cancer

Kenar G., KÖKSOY E. B., ÜRÜN Y., UTKAN G.

SUPPORTIVE CARE IN CANCER , cilt.28, sa.11, ss.5235-5242, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

Sweet's syndrome under ipilimumab therapy and a brief comparison of the cases in literature

Yasar H. A., AKKUŞ E., HEPER A., Akay B. N., ÜRÜN Y., UTKAN G.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.26, sa.7, ss.1762-1764, 2020 (SCI-Expanded)

A clinical dilemma amid COVID-19 pandemic: missed or encountered diagnosis of cancer?

Yekeduz E., Karcioglu A. M., UTKAN G., ÜRÜN Y.

FUTURE ONCOLOGY , cilt.16, sa.25, ss.1879-1881, 2020 (SCI-Expanded)

Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab

Yekeduz E., DURSUN B., Aydin G., YAZGAN S. C., Ozturks H. H., AZAP A., et al.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , sa.5, ss.1289-1294, 2020 (SCI-Expanded)

The relationship between prognostic nutritional index and treatment response in patients with metastatic renal cell cancer

Yasar H. A., Yucel K. B., Arslan C., Ucar G., Karakaya S., Bilgin B., et al.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.26, sa.5, ss.1110-1116, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

A systematic review: Role of systemic therapy on treatment and prevention of brain metastasis in renal cell carcinoma

Yekeduz E., Arzu Yasar H. A., UTKAN G., ÜRÜN Y.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.26, sa.4, ss.972-981, 2020 (SCI-Expanded)

Prognostic factors for survival in patients with mucosal and ocular melanoma treated with ipilimumab: Turkish Oncology Group study

Yasar H. A., Turna H., Esin E., Sedef A. M., Alkan A., Oksuzoglu B., et al.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.26, sa.2, ss.267-272, 2020 (SCI-Expanded)

Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study

ÜRÜN Y., Yasar H. A., TURNA Z. H., Esin E., Sedef A. M., Alkan A., et al.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.25, sa.7, ss.1658-1664, 2019 (SCI-Expanded)

Diagnostic serum vitamin D level is not a reliable prognostic factor for resectable breast cancer

Kaya D. M., Orturk B., Kubilay P., Onur H., UTKAN G., ÇAY ŞENLER F., et al.

FUTURE ONCOLOGY , cilt.14, sa.15, ss.1461-1467, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

Independent prognostic value of inflammation in metastatic pancreatic cancer.

Oksuzoglu B., Esin E., Koksoy E. B., Demirci N. S., Sendur M. A. N., Dede I., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.36, sa.15, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

Comparison of gemcitabine monotherapy with gemcitabine and cisplatin combination in metastatic pancreatic cancer: a retrospective analysis

Ergun Y., Ozdemir N. Y., Guner E. K., Esin E., ŞENDUR M. A. N., KÖKSOY E. B., et al.

JOURNAL OF BUON , cilt.23, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

Vaccination in oncology practice and predictors

Alkan A., Karci E., Yasar A., Tuncay G., KÖKSOY E. B., Urun M., et al.

SUPPORTIVE CARE IN CANCER , cilt.25, sa.9, ss.2677-2682, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

The significance of serum leptin level in patients with early stage nonsmall cell lung cancer

Karatas F., YALÇIN B., Sahin S., AKBULUT H., UTKAN G., DEMİRKAZIK A., et al.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , cilt.13, sa.2, ss.204-207, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

Widespread Metastatic Prostate Carcinoma Shown by 68Ga-PSMA PET/CT

SOYDAL Ç., ÖZKAN E., Yerlikaya H., UTKAN G., KÜÇÜK N. Ö.

CLINICAL NUCLEAR MEDICINE , cilt.41, sa.6, 2016 (SCI-Expanded)

Sweet Syndrome After Autologous Stem Cell Transplant

Alkan A., Idemen C., HEPER A., UTKAN G.

EXPERIMENTAL AND CLINICAL TRANSPLANTATION , cilt.14, sa.1, ss.109-111, 2016 (SCI-Expanded)

Radiation-Induced Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia

Alkan A., Kutuk T., Karci E., Yasar A., Hicsonmez A., UTKAN G.

TURKISH JOURNAL OF HEMATOLOGY , cilt.33, sa.3, ss.248-250, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

Lung Adenocarcinoma and Synchronous B-Cell Lymphoma of Stomach

ŞEN E., Yasar A., SAK S., UTKAN G., Erden E., SARYAL S. B.

CHEST , cilt.148, sa.4, 2015 (SCI-Expanded)

The more we use, the more we lose

Alkan A., Mizrak D., UTKAN G.

MEDICAL ONCOLOGY , cilt.32, sa.4, 2015 (SCI-Expanded)

The role of cardiac biomarkers as predictors of trastuzumab cardiotoxicity in patients with breast cancer

ÜRÜN Y., UTKAN G., Yalcin B., AKBULUT H., Onur H., Oztuna D., et al.

Experimental Oncology , cilt.37, sa.1, ss.53-57, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

First-Line Crizotinib in ALK-Positive Lung Cancer

Alkan A., KÖKSOY E. B., UTKAN G.

NEW ENGLAND JOURNAL OF MEDICINE , cilt.372, sa.8, ss.781-782, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

Medication errors in chemotherapy preparation and administration: A survey conducted among oncology nurses in Turkey

Ulas A., Silay K., Akinci S., Dede D. S., AKINCI M. B., ŞENDUR M. A. N., et al.

Asian Pacific Journal of Cancer Prevention , cilt.16, sa.5, ss.1699-1705, 2015 (SCI-Expanded)

The clinicopathological characteristics with long-term outcomes in malignant mesothelioma

Dogan M., UTKAN G., Hocazade C., Uncu D., Toptas S., Ozdemir N., et al.

MEDICAL ONCOLOGY , cilt.31, sa.10, 2014 (SCI-Expanded)

Cetuximab Related Eyelash Elongations for Patients with Metastatic Rectum Carcinoma: Metabolic Complete Response

ÜRÜN Y., UTKAN G.

ANNALS OF DERMATOLOGY , cilt.25, sa.4, ss.504-505, 2013 (SCI-Expanded)

Intraabdominal follicular dendritic cell sarcoma: A report of three cases and review of the literature

ÜRÜN Y., Kankaya D., Koral L., YALÇIN B., Karabork A., CEYHAN K., et al.

Tumori , cilt.99, sa.2, 2013 (SCI-Expanded)

Clinicopathological Features of Patients with Malignant Mesothelioma in a Multicenter, Case-Control Study: No Role for ABO-Rh Blood Groups

UTKAN G., ÜRÜN Y., KAYI CANGIR A., Kilic D., Ozdemir N. Y., Oztuna D., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , sa.1, ss.249-253, 2013 (SCI-Expanded)

Isolated Pulmonary Metastasis Presenting with an CEA Elevation Five Years After Radical Prostatectomy

ÜRÜN Y., UTKAN G., Percinel S., KAYI CANGIR A., Dogani M., Icli F.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.23, sa.3, ss.200-201, 2013 (SCI-Expanded)

Association of ABO Blood Group and Risk of Lung Cancer in a Multicenter Study in Turkey

ÜRÜN Y., UTKAN G., KAYI CANGIR A., Oksuzoglu O. B., Ozdemir N., Oztuna D., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , sa.5, ss.2801-2803, 2013 (SCI-Expanded)

Malign peritoneal mesothelioma with nephrotic syndrome

DOĞAN M. K., Ozal G., SAVAŞ B., Gungor M., UTKAN G., Yalcin B., et al.

Bratislava Medical Journal , cilt.113, sa.1, ss.43-45, 2012 (SCI-Expanded)

Is obesity always a risk factor for all breast cancer patients? c-erbB2 expression is significantly lower in obese patients with early stage breast cancer

Mousa U., Onur H., UTKAN G.

Clinical and Translational Oncology , cilt.14, sa.12, ss.923-930, 2012 (SCI-Expanded) Sürdürülebilir Kalkınma

Retrospective analysis of seventy-one patients with neuroendocrine tumor and review of the literature

Dogan M., Yalcin B., Ozdemir N. Y., Arslan U. Y., Dogan L., UTKAN G., et al.

MEDICAL ONCOLOGY , cilt.29, sa.3, ss.2021-2026, 2012 (SCI-Expanded) Sürdürülebilir Kalkınma

Primary extranodal non-Hodgkin's lymphoma presenting as painful gingival swelling

ÜRÜN Y., Can F., BARIŞ E., AKBULUT H., UTKAN G., Içli F.

Experimental Oncology , cilt.34, sa.2, ss.134-135, 2012 (SCI-Expanded)

ABO and Rh Blood Groups and Risk of Colorectal Adenocarcinoma

ÜRÜN Y., Ozdemir N. Y., UTKAN G., AKBULUT H., SAVAŞ B., Oksuzoglu B., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , sa.12, ss.6097-6100, 2012 (SCI-Expanded)

Relationship Between Antimetabolite Toxicity and Pharmacogenetics in Turkish Cancer Patients

Dogan M., KARABULUT H. G., Tukun A., DEMİRKAZIK A., UTKAN G., Yalcin B., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.13, sa.4, ss.1553-1556, 2012 (SCI-Expanded)

Lack of Any Relationship between ABO and Rh Blood Groups and Clinicopathological Features in Patients with Gastrointestinal Stromal Tumors: Turkish Oncology Group

ÜRÜN Y., Utkan G., YALÇIN Ş., COŞKUN H. Ş., Kocer M., Ozdemir N. Y., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , sa.8, ss.4129-4131, 2012 (SCI-Expanded)

A rare gastric neoplasm: gastric medullary carcinoma

Dogan M., SAVAŞ B., UTKAN G., BAYAR S., ENSARİ A., Icli F.

MEDICAL ONCOLOGY , cilt.28, sa.4, ss.945-947, 2011 (SCI-Expanded)

Kikuchi - Fujimoto disease: Cervical lymphadenopathy suggestive of relapsing lymphoma in patient with lymphoblastic lymphoma

ÜRÜN Y., UTKAN G., Kankaya D., DOĞAN M. K., YALÇIN B., Icli F.

Experimental Oncology , cilt.33, sa.4, ss.242-244, 2011 (SCI-Expanded)

Optimal timing of adjuvant treatment in patients with early breast cancer

Alkis N., Durnali A. G., Arslan U. Y., Kocer M., Onder F. O., Tokluoglu S., et al.

Medical Oncology , cilt.28, sa.4, ss.1255-1259, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma

Two cases with atypical metastasis in colorectal cancer: Splenic and renal metastasis

DOĞAN M. K., Ozal G., Ekinci C., UTKAN G., ÜRÜN Y., Yalcin B., et al.

Experimental Oncology , cilt.32, sa.4, ss.277-279, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma

Fifty-one Kaposi sarcoma patients

Dogan M., Dogan L., ÖZDEMİR F., Ozdemir N. Y., COŞKUN H. Ş., Arslan U. Y., et al.

CLINICAL & TRANSLATIONAL ONCOLOGY , cilt.12, sa.9, ss.629-633, 2010 (SCI-Expanded)

The Prognostic Importance of Leucocytosis, Thrombocytosis and Serum Vascular Endothelial Growth Factor (VEGF) Level in Inoperable Non-Small Cell Lung Cancer (NSCLC): A Match-Pair Analysis

DEMİRKAZIK A., Asik M., Yalcin B., Dogan M., Buyukcelik A., Sencan O., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.20, sa.1, ss.14-19, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma

Activity of pemetrexed on brain metastases from non-small cell lung cancer: What is the mechanism?

Dogan M., Yalcin B., UTKAN G., ÜRÜN Y., Ozal G.

LUNG CANCER , cilt.66, sa.3, ss.399, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma

Angiotensin-converting enzyme inhibitors: Do they contribute to delayed chemotherapy induced nausea and vomiting?

Dogan M., Yalcin B., Ozal F. G., Buyukcelik A., UTKAN G., Icli F., et al.

Medical Hypotheses , cilt.73, sa.4, ss.628-629, 2009 (SCI-Expanded)

Low molecular weight heparin (LMWH) increases the efficacy of cisplatinum plus gemcitabine combination in advanced pancreatic cancer

Icli F., AKBULUT H., Utkan G., Yalcin B., Dincol D., Isikdogan A., et al.

JOURNAL OF SURGICAL ONCOLOGY , cilt.95, sa.6, ss.507-512, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

Alpha fetoprotein producing gastric hepatoid adenocarcinoma

UTKAN G., Büyükçelik A., CEYHAN K., Ortabozkoyun L., Tek I., Yalçin B., et al.

Journal of the Pakistan Medical Association , cilt.56, sa.6, ss.292-293, 2006 (SCI-Expanded)

An unspecified neurologic paraneoplastic syndrome pointing out an occult relapse of ovarian cancer: A case report

Büyükçelik A., DEMİRKAZIK A., Yalçin B., Şener Ö., UTKAN G., Tulunay G., et al.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.15, sa.4, ss.199-202, 2005 (SCI-Expanded) Sürdürülebilir Kalkınma

Intracranial aggressive fibromatosis presenting as panhypopituitarism and diabetes insipidus

Gursoy A., Cesur M., Aktaş B., UTKAN G., Gedik V. T., ERDOĞAN M. F., et al.

Pituitary , cilt.8, sa.2, ss.123-126, 2005 (SCI-Expanded) Sürdürülebilir Kalkınma

Adjuvant Chemotherapy for Lung Cancer [1] (multiple letters)

Ikhlaque N., Baumann M. A., Büyükçelik A., UTKAN G., Yalçin B., Feliu J., et al.

New England Journal of Medicine , cilt.350, sa.16, ss.1681-1683, 2004 (SCI-Expanded) Sürdürülebilir Kalkınma

The prognostic Importance of Venous Thromboembolism (VT) in cancer patients and its relationship with the ieveis of factor VIII and Vascular Endothelial Growth Factor (VEGF)

DEMİRKAZIK A., Dogan M., Konuk N., AKBULUT H., Yalcin B., Buyukcelik A., et al.

ANNALS OF ONCOLOGY , cilt.15, ss.151, 2004 (SCI-Expanded) Sürdürülebilir Kalkınma

Diğer Dergilerde Yayınlanan Makaleler

Enhancing the Anti-angiogenic Effect of Bevacizumab with ACE Inhibition on mCRC

ERDAT E. C., KÖKSOY E. B., UTKAN G.

JOURNAL OF GASTROINTESTINAL CANCER , cilt.54, sa.3, ss.897-902, 2023 (ESCI)

The relationship between body mass index and clinical properties/survival in patients with breast cancer

ERDOĞDU B., UTKAN G.

The European Research Journal , cilt.9, sa.4, ss.770-778, 2023 (Hakemli Dergi)

Relationship Between ABO Blood Group and Microsatellite Instability in Colorectal Cancer: A Retrospective Single-Center Study

Karaoglan B. B., AKYOL C., ÜNAL A. E., Kuzu A., SAVAŞ B., UTKAN G.

JOURNAL OF GASTROINTESTINAL CANCER , 2023 (ESCI)

Lokal ileri rektum kanserinde sağkalımı etkileyen faktörler - Tek merkez deneyimi

Yasar H. A., Örüncü M. B., UTKAN G., Akbulut H.

Akademik Gastroenteroloji Dergisi , cilt.22, sa.2, ss.71-76, 2023 (Hakemli Dergi)

Mide kanseri ve ABO kan grubu ilişkisi: çok merkezli, gözlemsel, vaka-kontrol çalışması

Yasar H. A., UTKAN G., Ozdemir N., oksuzoglu b., DEDE İ., ÜRÜN Y., et al.

Akademik Gastroenteroloji Dergisi , cilt.22, sa.2, ss.67-70, 2023 (Hakemli Dergi)

Systemic Immune-Inflammation Index as a Prognostic Marker of Late Recurrence in Operable Gastric Cancer: a Dual-Center Study

Yekeduz E., DOĞAN İ., Kaya D. M., ÖZGÜR İ., UTKAN G., VATANSEVER S., et al.

JOURNAL OF GASTROINTESTINAL CANCER , cilt.53, sa.4, ss.870-879, 2022 (ESCI)

Predictive Factor for Lymph Node Metastasis in Non-Metastatic Colorectal Adenocarcinomas

Karcı E., Ürün Y., Köksoy E. B., Yekedüz E., Utkan G., Akbulut H., et al.

Eurasian Journal of Medical Investigation , cilt.6, sa.3, ss.279-283, 2022 (Hakemli Dergi)

Genomic Landscape of Actionable Mutations in Primary and Metastatic Tissues of Colon Adenocarcinoma

Yekeduz E., AKBULUT H., UTKAN G., ÜRÜN Y.

CUREUS JOURNAL OF MEDICAL SCIENCE , cilt.14, sa.4, 2022 (ESCI)

Sorafenib in Radioactive Iodine Refractory Differentiated Thyroid Cancer: A Real-life Data with Long-term Experience

Yekedüz E., Köksoy E. B., Şenler F., Akbulut H., Demirkazık A., Ürün Y., et al.

Ankara Üniversitesi Tıp Fakültesi Mecmuası , cilt.75, sa.1, ss.103-106, 2022 (Hakemli Dergi)

The relationship between clinicopathological parameters and PD-L1 expression level in advanced stage non-small cell lung cancer

Gurbuz M., DOĞAN İ., AKKUŞ E., ÖZAKINCI H., Tolunay P. K., KALACI E., et al.

TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX , cilt.70, sa.2, ss.132-140, 2022 (ESCI)

Association between blood type and epidermal growth factor receptor mutation positivity in lung adenocarcinoma patients

Gürbüz M., AKKUŞ E., Karaalioğlu B., Aktaş E. G., KÖKSOY E. B., ÖZAKINCI H., et al.

Journal of Oncological Science , cilt.7, sa.1, ss.20-24, 2021 (Scopus)

Seasonal influenza and pneumococcal vaccination rates among patients with cancer in covid-19 pandemic: A cross-sectional study

Yekedüz E., KÖKSOY E. B., YAZGAN S. C., AKBIYIK I., BALLI S., Kavak E. E., et al.

Journal of Oncological Science , cilt.7, sa.2, ss.64-70, 2021 (Scopus)

Efficacy of Chemotherapy Combinations in Metastatic Castration-Resistant Prostate Cancer Patients - Do Homologous Recombination Deficiency Affect the Outcomes?

Yekeduz E., UTKAN G., ÜRÜN Y.

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , cilt.19, sa.4, ss.175-176, 2020 (ESCI) Sürdürülebilir Kalkınma

Intense F-18-Flourodeoxyglucose Uptake in Brachial Plexus of Patients with Brachial Plexopathy

Soydal Ç., Gündüz P., Araz M., Utkan G.

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY , cilt.29, sa.2, ss.79-81, 2020 (ESCI)

Intense 18F-Flourodeoxyglucose Uptake in Brachial Plexus of Patients with Brachial Plexopathy

SOYDAL Ç., AKKUŞ P., ARAZ M., UTKAN G.

Molecular Imaging and Radionuclide Therapy , cilt.29, sa.2, ss.79-81, 2020 (ESCI)

The COVID 19 Pandemic and Colorectal Cancer: 5W1H - What Should We Do to Whom, When, Why, Where and How?

AKYOL C., KOÇ M. A., UTKAN G., YILDIZ F., KUZU M. A.

Turkish Journal of Colorectal Disease , cilt.30, ss.67-75, 2020 (Hakemli Dergi) Sürdürülebilir Kalkınma

The Impact of Loneliness and Cancer Diagnosis on Cognitive Impairment in Geriatric Patients

ALKAN A., ÜRÜN Y., UTKAN G., AKBULUT H., TUNCAY G., ARAS S., et al.

Journal of Oncological Sciences , cilt.6, sa.2, ss.65-70, 2020 (Hakemli Dergi) Sürdürülebilir Kalkınma

The Impact of Loneliness and Cancer Diagnosis on Cognitive Impairment in Geriatric Patients.

ALKAN A., ÖZTORUN H. S., KARCI E., ÜRÜN Y., TUNCAY G., YAŞAR H. A., et al.

Journal of Oncological Sciences , cilt.6, sa.2, ss.65-70, 2020 (Hakemli Dergi)

Risk factors for thrombosis risk in patients with cancer

TURAN D., YAŞAR H. A., Aksu O. B., KÖKSOY E. B., UTKAN G., AKBULUT H., et al.

Journal of Oncological Sciences , cilt.4, sa.3, ss.130-133, 2018 (Hakemli Dergi) Sürdürülebilir Kalkınma

Osteonecrosis of the jaw with sunitinib and zoledronic acid combination: A case report

Tolunay P. K., YAŞAR H. A., UTKAN G., ÜRÜN Y.

Journal of Oncological Sciences , cilt.4, sa.2, ss.116-118, 2018 (Hakemli Dergi)

Inadequate Nutritional Status of Hospitalized Cancer Patients

ALKAN A., MIZRAK KAYA D., ÇAY ŞENLER F., UTKAN G.

Journal of Clinical and Experimental Investigations , cilt.8, sa.01, ss.12-17, 2017 (Hakemli Dergi)

Oxaliplatin-induced Autoimmune Hemolitic Anemia

YAŞAR H. A., ŞAHİN U., SAĞLAM K., ALKAN A., UTKAN G.

Acta Oncologica Turcica , cilt.50, sa.2, ss.174-177, 2017 (Hakemli Dergi)

Widespread Metastatic Involvement in a Patient with Merkel Cell Carcinoma on 68Ga-DOTATATE PET/CT: Case Report

ÖZKAN E., SOYDAL Ç., ALKAN A., UTKAN G.

Turkiye Klinikleri Journal of Case Reports , cilt.25, sa.1, ss.10-13, 2017 (Hakemli Dergi)

Oxaliplatin-induced Autoimmune Hemolitic Anemia

YAŞAR H. A., ŞAHİN U., Sağlam K., ALKAN A., UTKAN G.

ACTA ONCOLOGICA TURCICA , cilt.50, sa.2, ss.174-177, 2017 (Hakemli Dergi)

Porphyria A Rare Cause of Neurological Symptoms in Cancer Patient

ALKAN A., karcı E., YAVUZ VEİZİ B. G., Akıncı N., AKDAĞ A., YAŞAR H. A., et al.

ACTA ONCOLOGICA TURCICA , cilt.49, sa.3, ss.251-254, 2016 (Hakemli Dergi) Sürdürülebilir Kalkınma

Osteogenesis Imperfecta, Pseudoachalasia, and Gastric Cancer

Mizrak D., Alkan A., Erdogdu B., UTKAN G.

CASE REPORTS IN GASTROINTESTINAL MEDICINE , cilt.2015, 2015 (ESCI) Sürdürülebilir Kalkınma

Paraneoplastic digital necrosis associated with rectum carcinoma

ALKAN A., ÖZGÜL S., YAŞAR H. A., karcı E., KÖKSOY E. B., UTKAN G.

Journal of Clinical and Experimental Investigations , cilt.6, sa.4, ss.391-392, 2015 (Hakemli Dergi)

Widespread erythematous skin metastasis from breast cancer mimicking generalized drug eruption

UTKAN G., Büyükçelik A., Okçu A., Avci U., Yalçin B., Içli F.

Turkish Journal of Cancer , cilt.39, sa.2, ss.66-68, 2009 (Scopus) Sürdürülebilir Kalkınma

The clinical and pathological features of patients with gastric cancer in Turkey: A Turkish Oncology Group Study

Yalçin B., Zengin N., AYDIN F., Ilhan M., Işikdoǧan A., Demir G., et al.

Turkish Journal of Cancer , cilt.36, sa.3, ss.108-115, 2006 (Scopus) Sürdürülebilir Kalkınma

Frequency of symptoms in patients with advanced cancer

Yalçin B., Büyükçelik A., Şenler F. Ç., UTKAN G., Tek I., Doǧan M., et al.

Turkish Journal of Cancer , cilt.35, sa.4, ss.177-180, 2005 (Scopus) Sürdürülebilir Kalkınma

The opinions of the cancer patients about pain management: A questionnaire study

Yalçin B., Şenler F. Ç., Büyükçelik A., UTKAN G., Tek I., Doruk H., et al.

Turkish Journal of Cancer , cilt.34, sa.3, ss.114-117, 2004 (Scopus) Sürdürülebilir Kalkınma

Adrenal gland insufficiency in a patient with non-small cell lung cancer: Case report and review of the literature Adrenal gland yetmezliǧi gelişen bir küçük hücreli dişi akciǧer kanseri olgusu: Olgu sunumu ve literatürün gözden geçirilmesi

Büyüçelik A., UTKAN G., DEMİR Ö., Yalçin B., DEMİRKAZIK A., Içli F.

THOD - Turk Hematoloji-Onkoloji Dergisi , cilt.12, sa.4, ss.210-214, 2002 (Scopus) Sürdürülebilir Kalkınma

Hakemli Kongre / Sempozyum Bildiri Kitaplarında Yer Alan Yayınlar

GİST HASTALARINDA İMATİNİB ALTINDA KAN LİPİD DÜZEYİ DEĞİŞİKLİKLERİ

KÖKSOY E. B., KARCI E., ÜRÜN M., YAŞAR H. A., ÖZYURT N., UTKAN G., et al.

22. Ulusal Kanser Kongresi, Antalya, Türkiye, 19 - 23 Nisan 2017, ss.441

Metastatik kororektal karsinomda TARE etkinliği, tek merkez deneyimi.

DURSUN B., DEMİR B., SOYDAL Ç., UTKAN G.

9.Türk Tıbbi Onkoloji Derneği Kongresi, Kıbrıs (Kktc), 18 Mayıs 2022

Nüks folliküler lenfoma olgusunda prostat tutulumu

ÖZYURT N., YAŞAR H. A., GÜRBÜZ M., KUBİLAY TOLUNAY P., YEKEDÜZ E., KARAALİOĞLU B., et al.

23. Ulusal Kanser Kongresi, Antalya, Türkiye, 17 - 21 Nisan 2019, ss.442

Nazofarenks Kanserli Hastalarda Sağkalım İle İlişkili Prognostik Faktörler

YAŞAR H. A., KUBİLAY TOLUNAY P., DEMİRKIRAN A., KARAAĞAÇ M., GÜMÜŞTEPE E., UTKAN G., et al.

23. Ulusal Kanser Kongresi, Antalya, Türkiye, 17 - 21 Nisan 2019

Efficacy of The Second-line Treatment in Metastatic Pancreas Cancer

ŞENDUR M. A. N., BİLGİN B., KARCI GÜNER E., HIZAL M., ERGÜN Y., ESİN E., et al.

8th International Gastrointestinal Cancer Conference, İstanbul, Türkiye, 7 - 09 Aralık 2018 Sürdürülebilir Kalkınma

DETERMINATION OF THE PROGNOSTICMARKERS BEFORE SECONDLINE TREATMENT INMETASTATIC PANCREAS CANCER

BİLGİN B., karcı e., ŞENDUR M. A. N., hızal m., yakup e., esin e., et al.

8 th INTERNATIONALGASTROINTESTINALCANCER CONFERENCE, 7 - 09 Aralık 2018 Sürdürülebilir Kalkınma

MIDE KANSERI VE ABO KAN GRUBU İLIŞKISI: ÇOK MERKEZLI, GÖZLEMSEL, VAKA-KONTROL ÇALIŞMASI

YAŞAR H. A., UTKAN G., ÖZDEMİR N., ÇAKMAK ÖKSÜZOĞLU Ö. B., DEDE İ., ÜRÜN Y., et al.

7. Türk Tıbbı Onkoloji Kongresi, Antalya, Türkiye, 21 - 25 Mart 2018, ss.443

NADIR BIR VAKA: SEFUROKSIM KULLANIMI SONRASINDA GELIŞEN RADYASYON RECALL DERMATITI

YAŞAR H. A., KUBİLAY TOLUNAY P., ÜRÜN Y., UTKAN G.

7. Türk Tıbbı Onkoloji Kongresi, Antalya, Türkiye, 21 - 25 Mart 2018, ss.282

Pankreas Kanseri ve ABO Kan Grubu İliskisi: Çok Merkezli, Gözlemsel, Vaka-Kontrol Çalışması

KÖKSOY E. B., UTKAN G., ERGÜN Y., ESİN E., ŞENDUR M. A. N., KARCI GÜNER E., et al.

7. Türk Tıbbi Onkoloji Kongresi, Antalya, Türkiye, 21 - 25 Mart 2018 Sürdürülebilir Kalkınma

NADIR GÖRÜLEN İPILIMUMAB TOKSISITESI: ERITEMA NODOSUM

YAŞAR H. A., ÖZYURT N., UTKAN G.

7. Türk Tıbbı Onkoloji Kongresi, Antalya, Türkiye, 21 - 25 Mart 2018, ss.341

TIROZIN KINAZ İNHIBITÖRÜ ILE TEDAVI EDILEN METASTATIK RENAL HÜCRELI KANSER OLGULARINDA SISTEMIK İMMÜN İNFLAMASYON İNDEKSININ TEDAVI YANITI ILE İLIŞKISI

BİR YÜCEL K., YAŞAR H. A., UÇAR G., UTKAN G., ÖZDEMİR N., ÜRÜN Y.

7. Türk Tıbbı Onkoloji Kongresi, Antalya, Türkiye, 21 - 25 Mart 2018, ss.177

Metastatik Pankreas Kanserinde 2. Basamak Tedavilerin Etkinliği

ŞENDUR M. A. N., BİLGİN B., KARCI GÜNER E., ERGÜN Y., ESİN E., KÖKSOY E. B., et al.

7. Türk Tıbbi Onkoloji Kongresi, Antalya, Türkiye, 21 - 25 Mart 2018 Sürdürülebilir Kalkınma

SUNITINIB VE ZOLEDRONIK ASIT KULLANIMI İLE GELIŞEN ÇENE OSTEONEKROZU VAKASI

KUBİLAY TOLUNAY P., YAŞAR H. A., ÜRÜN Y., UTKAN G.

7. Türk Tıbbı Onkoloji Kongresi, Antalya, Türkiye, 21 - 25 Mart 2018, ss.287

SYSTEMIC IMMUNE INFLAMMATION INDEX AND TREATMENT RESPONSE IN PATIENTS WITH METASTATIC RENAL CELL CANCER

BİR YÜCEL K., YAŞAR H. A., UÇAR G., UTKAN G., ÖZDEMİR N., ÜRÜN Y.

2018 GENITOURINARY CANCERS SYMPOSIUM, SAN-FRANCISCO,CALIFORNIA, Amerika Birleşik Devletleri, 8 - 10 Şubat 2018, cilt.36, ss.591

Systemic immune inflammation index and treatment response in patients with metastatic renal cell cancer.

Yacel K. B., Yasar A., Ucar G., Utkan G., Yildirim N., ÜRÜN Y.

Genitourinary Cancers Symposium, San-Francisco, Kostarika, 8 - 10 Şubat 2018, cilt.36 Sürdürülebilir Kalkınma

Relationship between metabolic parameters and ras mutation status

KARCI E., SOYDAL Ç., UTKAN G., ÜRÜN Y., AKBULUT H.

30th Annual Congress of the European Association of Nuclear Medicine, 21 - 25 Ekim 2017, cilt.44, ss.696

Asingle center analysis of evolving experience with ALPPS procedure: Towards better patient and graft selection

BALCI D., KIRIMKER E. O., ÖZÇELİK M., ÜSTÜNER E., KONCA C., UTKAN G., et al.

12th Biennial E-AHPBA Congress 2017, Mainz, Almanya, 23 - 26 Mayıs 2017

Kalp ve Beyin Metastatik Yassı Hücreli Dil Karsinomu Olgusu

ÜRÜN M., ÖZYURT N., KÖKSOY E. B., YAŞAR H. A., KARCI E., UTKAN G., et al.

22. Ulusal Kanser Kongresi, Antalya, Türkiye, 19 - 23 Nisan 2017, ss.321

Onkoloji pratiğinde aşılama ve etkileyen faktörler

ALKAN A., karcı E., YAŞAR H. A., Tuncay G., KÖKSOY E. B., Ürün M., et al.

22. Ulusal Kanser Kongresi, Türkiye, 19 - 23 Nisan 2017 Sürdürülebilir Kalkınma

Metastatik Olmayan Kolorektal Adenokanserlerde Lenf Nodu Metastazı İçin Prediktif Faktörlerin Değerlendirilmesi

KARCI E., KÖKSOY E. B., HOCAZADE C., BİLGİN B., ALKAN A., DEDE İ., et al.

22. ULUSAL KANSER KONGRESİ, Antalya, Türkiye, 19 Nisan 2017, ss.242-243

TRPredictive factors of lymph node metastasis in patients with non metastatic colorectal Adenocarcinoma

Karcı E., KÖKSOY E. B., ALKAN A., Dede İ., Tuncay G., UTKAN G., et al.

ESMO Congress, 7 - 11 Ekim 2016

Vaccination in oncology practice and predictors

ALKAN A., KARCI E., YAŞAR H. A., TUNCAY G., ÜRÜN M., KÖKSOY E. B., et al.

ESMO, 7 - 10 Ekim 2016

Medical oncologists attitudes towards vaccination inoncology practice

ALKAN A., karcı e., YAŞAR H. A., tuncay g., ürün m., KÖKSOY E. B., et al.

ESMO annual meeting, 7 - 11 Ekim 2016

Nadir bir vaka: Safra kesesi nöroendokrin tümörü

YAŞAR H. A., ALKAN A., BUDAK B., KÖKSOY E. B., UTKAN G.

6. Türk Tıbbi Onkoloji kongresi, Antalya, Türkiye, 23 - 27 Mart 2016, ss.538

Kanser hastasında nadir bir pansitopeni nedeni: Folik asit eksikliği

YAŞAR H. A., ŞAHİN G., ALKAN A., karcı E., UTKAN G.

6. Türk Tıbbi Onkoloji kongresi, Antalya, Türkiye, 23 - 27 Mart 2016, ss.442

A Rare Cause of Endobronchial Metastasis: Malignant Melanoma

EROL S., ÇİLEDAĞ A., Karacay E., Kaya A., Ciledag N., KARNAK D., et al.

CHEST Annual Meeting, Montreal, Kanada, 25 - 28 Ekim 2015

A Rare Cause of Endobronchial Metastasis:Malignant Melanom

KAYA A., ÇİLEDAĞ A., KARAÇAY E., GÜRÜN KAYA A., ÇİLEDAĞ N., UTKAN G., et al.

American Thoracic Society Congress 2015, Amerika Birleşik Devletleri, 15 - 20 Mayıs 2015

The significance of the serum leptin, ghrelin, tumor necrosis factor alpha and interleukine-1 levels in patients with non-small cell lung cancer

Karatas F., Yalcin B., AKBULUT H., Utkan G., Sahin S., DEMİRKAZIK A., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33 Sürdürülebilir Kalkınma

Sequential use of bevacizumab and cetuximab in patients with K-RAS wild type advanced colorectal cancer.

AKBULUT H., Gercik O., Icli F., Mizrak D., DEMİRKAZIK A., Onur H., et al.

Clinical experience with Vemurafenib in pretreated melanoma (MEL): The results of open label multi center study from Turkey

Celik I., Mandel N. M., Gokmen E., Unal O. U., Sevinc A., COŞKUN H. Ş., et al.

Associating liver partition with portal vein ligation for staged hepatectomy for gastrointestinal cancer liver metastasis an initial experince with 12 cases

BALCI D., KONCA C., UZUN Ç., KIRIMKER E. O., ÖZÇELİK M., MEÇO B. C., et al.

11th International Congress of the European-African Hepato-Pancreato-Biliary Association, 21 - 24 Nisan 2015 Sürdürülebilir Kalkınma

ALPPS procedure for Colorectal Cancer Liver Metastasis Initial experience with 10 consecutive cases

BALCI D., KONCA C., UZUN Ç., KIRIMKER E. O., GÖKTUĞ U. U., ÖZÇELİK M., et al.

11th. International Congress of European-African Hepato-Pancreato-Biliary Association, Manchester, Birleşik Krallık, 21 - 24 Nisan 2015 Sürdürülebilir Kalkınma

Associating Liver Partition with Portal Vein Ligation for Staged Hepatectomy for Gastrointestinal Cancer Liver Metastasis An Initial Experience with 12 cases

BALCI D., KONCA C., UZUN Ç., ÖZÇELİK M., UTKAN G., MEÇO B. C., et al.

International Congress of European-African Hepato-Pancreato-Biliary Association, Manchester, Birleşik Krallık, 21 - 24 Nisan 2015 Sürdürülebilir Kalkınma